Yale Health Taps AI to Combat Looming Medicaid Coverage Crisis

OAKLAND, CA – May 13, 2026 – Yale New Haven Health (YNHHS), the largest healthcare system in Connecticut, has announced a partnership with financial AI firm Escher Health to address a growing challenge in American healthcare: ensuring vulnerable populations secure and maintain Medicaid coverage. The initiative deploys artificial intelligence to navigate an increasingly complex administrative landscape, aiming to prevent patients from falling through the cracks as sweeping federal policy changes take effect.

The collaboration comes as health systems nationwide brace for the impact of H.R. 1, a significant budget reconciliation bill signed into law in July 2025. This legislation is set to dramatically reshape the Medicaid program, which provides a critical safety net for millions of low-income Americans.

A Looming National Coverage Cliff

The changes mandated by H.R. 1 present formidable hurdles for both patients and providers. The Congressional Budget Office (CBO) projects that these new policies will cause 11.8 million people to lose their Medicaid coverage over the next decade. This coverage loss is anticipated to stem from several key provisions.

Starting in 2027, the law introduces new work reporting requirements for many adult enrollees and shortens the window for retroactive coverage. Perhaps most significantly for administrative burden, it mandates that eligibility for many adults be re-evaluated every six months instead of annually. This doubles the paperwork and potential for procedural errors that can lead to disenrollment, even for those who remain eligible.

These federal changes are compounding the disruption from the recent “Medicaid unwinding,” a process that began in 2023 when states resumed eligibility checks after a pause during the COVID-19 pandemic. That process has already seen millions lose coverage, many for procedural reasons like missed paperwork rather than ineligibility. The new law threatens to create a similar, sustained wave of coverage loss, placing immense pressure on state agencies and healthcare providers.

A Proactive Strategy for Connecticut's Vulnerable

As the largest provider of Medicaid services in Connecticut, YNHHS is on the front lines of this issue. The health system’s partnership with Escher Health represents a proactive strategy to mitigate the local impact of these national policies. The goal is twofold: support continuity of care for patients and reduce the financial strain of uncompensated care on the health system.

"Yale New Haven is committed to making it easier for people to access the latest medical treatments, as seamlessly as possible," said Jonathan Davis, Executive Director of Patient Access at Yale New Haven Health. “By partnering with Escher Health, we aim to better support patients who may qualify for Medicaid but are not yet enrolled, while also helping reduce administrative barriers for both patients and our teams.”

For a system like YNHHS, which serves a large population through Connecticut's Medicaid program, known as HUSKY, successfully enrolling eligible patients is crucial. When a patient who qualifies for Medicaid remains unenrolled, the cost of their care often becomes bad debt or charity care for the hospital. This new initiative seeks to convert those potential losses into properly compensated care, improving the system’s financial stability.

"Our collaboration with Escher Health will help us proactively connect eligible individuals to coverage and care while improving operational efficiency across our patient access and revenue cycle workflows,” added Tina Ferreira, Director of Patient Financial Access at Yale New Haven Health.

Deploying AI to Navigate Bureaucracy

At the heart of the partnership is Escher Health's technology, which uses AI to automate and streamline the labyrinthine process of Medicaid enrollment. The company, which has already helped over 100,000 people enroll in safety-net programs, offers a platform designed to tackle the precise administrative bottlenecks that cause coverage gaps.

The AI-powered system works by first identifying patients within the health system who are likely eligible for Medicaid or other financial assistance programs but are not currently enrolled. It then automates outreach and guides patients through the application process using self-service tools like onsite kiosks and a multilingual interface.

According to Escher Health, its proprietary algorithms can check applications for completeness and accuracy before submission, and its automation bots can submit and track applications through government portals, a process that is often manual and time-consuming for hospital staff. This automation is intended to handle up to 90% of the enrollment workflow, freeing up human counselors to focus on more complex cases.

“Too many patients delay or forgo care because navigating eligibility and enrollment processes can be overwhelming,” said Pedram Afshar, CEO and founder of Escher Health. “We are proud to partner with forward-looking organizations like Yale New Haven Health to help patients access the right programs at the right time, while reducing administrative burden for healthcare staff.”

The Promise and Peril of AI in Patient Access

This partnership highlights a broader trend in the healthcare industry: turning to AI to solve persistent financial and operational challenges. For hospital CFOs and administrators, the business case is compelling. By reducing uncompensated care, minimizing claim denials, and lowering the administrative FTE burden, such technologies promise a significant return on investment. Competitors like Atlas Health and PayZen are also gaining traction by offering AI-driven platforms to manage patient affordability and streamline revenue cycles.

However, the growing use of AI to determine access to essential services like healthcare is not without its critics and ethical considerations. Experts in health policy and AI ethics caution against the risk of algorithmic bias. If AI models are trained on historical data that reflects existing societal inequities, they could inadvertently perpetuate them. For example, an algorithm might incorrectly flag certain demographic groups as less likely to complete an application, leading to less outreach and reinforcing barriers to care.

Transparency is another major concern. The “black box” nature of some complex algorithms can make it difficult to understand why a decision was made, posing challenges for accountability and appeals. In response to these risks, industry groups like the Coalition for Health AI (CHAI) have begun issuing best practice guides. They strongly recommend that any adverse decision, such as an enrollment denial, must involve a “human-in-the-loop” for final review, prohibiting fully automated denials that could wrongfully strip a person of their benefits.

As Yale New Haven Health and Escher Health move forward, their initiative will serve as a crucial case study. It will test the promise of AI to create a more efficient and humane system for healthcare access while navigating the profound ethical responsibility of deploying automated systems at such a critical intersection of technology and human welfare.